Neurobiological Technologies, Inc. Share Price Other OTC
Equities
NTII
US64124W3043
Pharmaceuticals
Sales 2008 | 14.76M 1.23B | Sales 2009 | 26.35M 2.2B | Capitalization | 18.18M 1.52B |
---|---|---|---|---|---|
Net income 2008 | -16M -1.34B | Net income 2009 | 3M 250M | EV / Sales 2008 | 0.56 x |
Net cash position 2008 | 29.98M 2.5B | Net cash position 2009 | 24.05M 2.01B | EV / Sales 2009 | -0.22 x |
P/E ratio 2008 |
-1.69
x | P/E ratio 2009 |
5.82
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+28.50% | 662B | |
+22.23% | 546B | |
-4.93% | 359B | |
+16.97% | 323B | |
+4.08% | 289B | |
+13.68% | 234B | |
+3.84% | 198B | |
-10.35% | 194B | |
+3.98% | 167B |